Position in AZN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$917,515,956
New position
Shares Held
4,652,246
first reported quarter
Ownership
0.300%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 85.81730200853524.ToString("F0")%
Shared 0.ToString("F0")%
None 14.182697991464769.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,760,772,587 across 11 Drug Manufacturers - General names. AZN ranks #1 (33.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
4,652,246 | $917,515,956 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
8,872,779 | $538,134,046 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,936,330 | $353,211,135 | |
| 4 | NVO |
Novo Nordisk A S
|
7,827,491 | $287,660,294 | |
| 5 | LLY |
ELI LILLY & Co
|
282,798 | $260,109,116 | |
| 6 | JNJ |
Johnson & Johnson
|
1,004,689 | $245,586,179 | |
| 7 | GSK |
GSK plc
|
1,621,397 | $89,484,900 | |
| 8 | ABBV |
AbbVie Inc.
|
122,181 | $26,573,145 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $917,515,956 | 4,652,246 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||